Douple Dip or No Double Dip? The Debate Continues…
Airtime: Tues. Jun. 22 2010 | 7:21 PM ET
Discussing the outlook for stocks and the economy, with Barry Ritholtz, Fusion IQ and Michael Pento, Delta Global Advisors.
Airtime: Tues. Jun. 22 2010 | 7:21 PM ET
Discussing the outlook for stocks and the economy, with Barry Ritholtz, Fusion IQ and Michael Pento, Delta Global Advisors.
Wilbur Ross on the Markets 2.2.10
Getting the word on the street, with Art Cashin, UBS.
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
GDP: Glass Half Full or Empty?
“The euro is a very credible currency, a currency that has a track record of keeping its value (and) is a major asset for investors,” ECB President Jean-Claude Trichet told CNBC after the central bank left interest rates on hold Thursday.
Forecasters warn the oil spill in the Gulf of Mexico could threaten the Mississippi and Alabama coasts as early ask this week. John Hofmeister, former CEO of US operations at Shell, shares his insight.